Abstracts tagged "health disparities and systemic lupus erythematosus (SLE)"

Abstract Number: 1853 • 2019 ACR/ARP Annual Meeting
Racial Differences in Highly Effective Contraceptive Use Among Medicaid Beneficiaries with SLE
Jessica Williams¹, Chang Xu ¹, Karen Costenbader ¹, Bonnie Bermas ², Lydia Pace ³ and Candace Feldman ³, ¹Brigham and Women's Hospital, Boston, MA, ²UT Southwestern, Dallas, ³Brigham and Women's Hospital, Boston
Background/Purpose: Highly effective contraception (HEC), which includes intrauterine devices, implants and sterilization, is safe for women with SLE and has a < 1% failure rate…
Abstract Number: 1844 • 2018 ACR/ARHP Annual Meeting
Racial Disparities and Accelerated SLE Mortality from a Population-Based Registry: The Georgia Lupus Registry
S. Sam Lim¹, Charles G. Helmick², Gaobin Bao³, Caroline Gordon⁴, Jennifer M. Hootman² and Cristina Drenkard⁵, ¹Emory University School of Medicine, Atlanta, GA, ²Arthritis Program, Centers for Disease Control and Prevention, Atlanta, GA, ³Department of Medicine, Division of Rheumatology, Emory University School of Medicine, Atlanta, GA, ⁴Rheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom, ⁵Medicine/Rheumatology, Emory University, Atlanta, GA
Background/Purpose: Population-based SLE mortality studies have depended on administrative data from vital statistics records to identify cases. However, a high proportion of SLE deaths have…
Abstract Number: 199 • 2017 ACR/ARHP Annual Meeting
Incremental Direct Medical Costs of Systemic Lupus Erythematosus Patients in the Years Preceding Diagnosis and the Impact of Sex: A General Population-Based Study
Natalie McCormick^1,2, Carlo Marra³ and J. Antonio Avina-Zubieta⁴, ¹Arthritis Research Canada, Richmond, BC, Canada, ²Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada, ³School of Pharmacy, University of Otago, Dunedin, New Zealand, ⁴Division of Rheumatology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada
Background/Purpose: Little is known about the healthcare costs of systemic lupus erythematosus (SLE) patients in the years leading up to SLE diagnosis. We estimated the…
Abstract Number: 1760 • 2016 ACR/ARHP Annual Meeting
Systemic Lupus Erythematosus in Immigrants: Results from the 1000 Canadian Faces of Lupus Study
Amber Cogar¹, Janet E. Pope², Earl Silverman³, Paul R. Fortin⁴, Carol Hitchon⁵, Ann E. Clarke⁶, Christian Pineau⁷, Sasha Bernatsky^8,9, C Douglas Smith¹⁰, Marie Hudson¹¹, Adam Huber¹², Lori B. Tucker¹³, Michel Zummer¹⁴, Gaëlle Chédeville¹⁵, Hector Arbillaga¹⁶, Deborah M. Levy¹⁷, Christine A. Peschken¹⁸ and Canadian Network for Improved Outcomes in Systemic Lupus Erythematosus, ¹Medicine, University of Manitoba, Winnipeg, MB, Canada, ²University of Western Ontario, St Joseph's Health Care, London, ON, Canada, ³University of Toronto, Toronto, ON, Canada, ⁴Medicine, CHU de Québec - Université Laval, Québec, QC, Canada, ⁵University of Manitoba, Winnipeg, MB, Canada, ⁶Division of Rheumatology, University of Calgary, Calgary, AB, Canada, ⁷Rheumatology, MUHC, Montreal, QC, Canada, ⁸Division of Rheumatolog, McGill University Health Center, Montreal, QC, Canada, ⁹Division of Rheumatology and Clinical Epidemiology, McGill University, Montreal, Quebec, QC, Canada, ¹⁰The Arthritis Centre, TOH Riverside Campus, Ottawa, ON, Canada, ¹¹Medicine/Rheumatology, Jewish General Hospital, Lady Davis Research Institute, Montreal, QC, Canada, ¹²IWK Health Centre, Halifax, NS, Canada, ¹³Pediatric Rheum/Rm K4-120, BC Childrens Hospital, Vancouver, BC, Canada, ¹⁴Rheumatology, Ch Maisonneuve-Rosemont, Montreal, QC, Canada, ¹⁵Rheumatology, McGill University, Montreal, QC, Canada, ¹⁶Calgary Rheumatology, Calgary, AB, Canada, ¹⁷Division of Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, ¹⁸Arthritis Center, University of Manitoba, Winnipeg, MB, Canada
Background/Purpose: Ethnic differences in SLE are well known, but little is known about SLE in patients who have immigrated to North America from elsewhere in…
Abstract Number: 1696 • 2013 ACR/ARHP Annual Meeting
Prevalence and Incidence of Systemic Lupus Erythematosus in a Population-Based Registry of American Indian and Alaska Native People in the United States, 2007-2009
Elizabeth D. Ferucci¹, Janet Johnston², Jasmine Gaddy³, Lisa Sumner⁴, James Posever⁴, Tammy L. Choromanski¹, Caroline Gordon⁵, S. Sam Lim⁶ and Charles G. Helmick⁷, ¹Division of Community Health Services, Alaska Native Tribal Health Consortium, Anchorage, AK, ²Institute for Circumpolar Health Studies, Univeristy of Alaska Anchorage, Anchorage, AK, ³Medicine/Rheumatology, Oklahoma City Area Indian Health Service, Oklahoma City, OK, ⁴Medicine/Rheumatology, Phoenix Indian Medical Center, Phoenix, AZ, ⁵Rheumatology Research Group (East Wing), School of Immunity and Infection, University of Birmingham, Birmingham, United Kingdom, ⁶Emory University School of Medicine, Division of Rheumatology, Atlanta, GA, ⁷National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA
Background/Purpose: Estimates of the prevalence and incidence of systemic lupus erythematosus (SLE) have varied widely but have consistently been high in women and minority…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].